Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
Related Posts
Why Chinese Are Rushing Into a ‘Casino’ Stock Market
Steps to bolster the economy have set off a stock buying frenzy. Our columnist spoke to Chinese investors about why they are jumping in knowing […]
After Trump’s Tariff Threat, Is a China Currency War Next?
While China could offset American tariffs by letting its currency fall, that might endanger Beijing’s recent efforts to stabilize the economy.
Nvidia’s Earnings Report: What to Watch
Investors have high hopes for the chipmaker, the world’s most valuable company, which has enormous influence over the stock market.